1. Clinical usefulness of digital twin guided virtual amiodarone test in patients with atrial fibrillation ablation.
- Author
-
Hwang, Taehyun, Lim, Byounghyun, Kwon, Oh-Seok, Kim, Moon-Hyun, Kim, Daehoon, Park, Je-Wook, Yu, Hee Tae, Kim, Tae-Hoon, Uhm, Jae-Sun, Joung, Boyoung, Lee, Moon-Hyoung, Hwang, Chun, and Pak, Hui-Nam
- Subjects
ATRIAL fibrillation risk factors ,DIGITAL technology ,RISK assessment ,BIOLOGICAL models ,COMPUTER simulation ,LEFT heart atrium ,PREDICTION models ,PATIENT safety ,T-test (Statistics) ,RECEIVER operating characteristic curves ,STATISTICAL significance ,RESEARCH funding ,COMPUTED tomography ,KRUSKAL-Wallis Test ,AMIODARONE ,MANN Whitney U Test ,DESCRIPTIVE statistics ,SURGICAL complications ,LOG-rank test ,ODDS ratio ,KAPLAN-Meier estimator ,ATRIAL fibrillation ,DRUG efficacy ,ANALYSIS of variance ,CATHETER ablation ,INDIVIDUALIZED medicine ,CONFIDENCE intervals ,DATA analysis software ,PROPORTIONAL hazards models ,REGRESSION analysis - Abstract
It would be clinically valuable if the efficacy of antiarrhythmic drugs could be simulated in advance. We developed a digital twin to predict amiodarone efficacy in high-risk atrial fibrillation (AF) patients post-ablation. Virtual left atrium models were created from computed tomography and electroanatomical maps to simulate AF and evaluate its response to varying amiodarone concentrations. As the amiodarone concentration increased in the virtual setting, action potential duration lengthened, peak upstroke velocities decreased, and virtual AF termination became more frequent. Patients were classified into effective (those with virtually terminated AF at therapeutic doses) and ineffective groups. The one-year clinical outcomes after AF ablation showed significantly better results in the effective group compared to the ineffective group, with AF recurrence rates of 20.8% vs. 45.1% (log-rank p = 0.031, adjusted hazard ratio, 0.37 [0.14-0.98]; p = 0.046). This study highlights the potential of a digital twin-guided approach in predicting amiodarone's effectiveness and improving personalized AF management. Clinical Trial Registration Name: The Evaluation for Prognostic Factors After Catheter Ablation of Atrial Fibrillation: Cohort Study, Registration number: NCT02138695. The date of registration: 2014-05. URL: https://www.clinicaltrials.gov; Unique identifier: NCT02138695. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF